PAM
RNTX
PVG Asset Management’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-117,600
| Closed | -$24.3K | – | 55 |
|
|
2022
Q3 | $24.3K | Buy |
+117,600
| New | +$24.3K | 0.09% | 35 |
|
|
2021
Q4 | $28.3K | Buy |
50,300
+26,745
| +114% | +$15.1K | 0.1% | 44 |
|
|
2021
Q3 | $24K | Buy |
23,555
+8,550
| +57% | +$8.73K | 0.07% | 39 |
|
|
2021
Q2 | $18.8K | Buy |
15,005
+650
| +5% | +$800 | 0.06% | 52 |
|
|
2021
Q1 | $20.5K | Buy |
+14,355
| New | +$20.5K | 0.07% | 46 |
|